This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera Protein, CF
catalog :
2017-T2-050
quantity :
50 ug
price :
443 USD
citations: 5
Reference
Chen Y, Xu K, Piccoli L, Foglierini M, Tan J, Jin W, et al. Structural basis of malaria RIFIN binding by LILRB1-containing antibodies. Nature. 2021;592:639-643 pubmed publisher
Martinez Martin N, Ramani S, Hackney J, Tom I, Wranik B, Chan M, et al. The extracellular interactome of the human adenovirus family reveals diverse strategies for immunomodulation. Nat Commun. 2016;7:11473 pubmed publisher
Li N, Fu L, Uchtenhagen H, Achour A, Burshtyn D. Cis association of leukocyte Ig-like receptor 1 with MHC class I modulates accessibility to antibodies and HCMV UL18. Eur J Immunol. 2013;43:1042-52 pubmed publisher
Baudhuin J, Lesport E, Sousa S, Migraine J, Vigneron J, Lemaoult J, et al. HLA-G inhibition of NK-cell cytolytic function is uncoupled from tumor cell lipid raft reorganization. Eur J Immunol. 2012;42:700-9 pubmed publisher
Verloes A, Van De Velde H, Lemaoult J, Mateizel I, Cauffman G, Horn P, et al. HLA-G expression in human embryonic stem cells and preimplantation embryos. J Immunol. 2011;186:2663-71 pubmed publisher
product information
master code :
2017-T2
SKU :
2017-T2-050
product name :
Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera Protein, CF
unit size :
50 ug
description :
The Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera Protein, CF from R&D Systems is derived from NS0. The Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera Protein, CF has been validated for the following applications: Bioactivity.
target :
LILRB1/CD85j/ILT2
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS.
conjugate :
Unconjugated
purity :
>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.
species :
Human
observed molecular weight :
106 kDa, reducing conditions
theoretical molecular weight :
73.8 kDa (monomer)
gene symbol :
LILRB1
details of functionality :
Measured by its ability to support the adhesion of HSB2 human peripheral blood acute lymphoblastic leukemia cells. Immobilized Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera at 5 ╡g/mL, 100 ╡L/well can support 60-80% HSB2 cell adhesion, when 1 x 105 cells were added in each well of a 96-well plate.
endotoxin note :
<0.10 EU per 1 ╡g of the protein by the LAL method.
top caption :
Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera Protein Binding Activity
accessionNumbers :
Q8NHL6
applications :
Bioactivity
source long :
Mouse myeloma cell line, NS0-derived human LILRB1/CD85j/ILT2 protein Human LILRB1/CD85j/ILT2 (Gly24-His458) Accession # Q8NHL6 IEGRMD Human IgG1 (Pro100-Lys330) N-terminus C-terminus
source short :
NS0
USD :
443 USD
alt names :
CD85 antigen-like family member J, CD85J, CD85j antigen, Ig-like transcript 2, ILT2, ILT-2, ILT2FLJ37515, Immunoglobulin-like transcript 2, leukocyte Ig-like receptor-1, Leukocyte immunoglobulin-like receptor 1, leukocyte immunoglobulin-like receptor subfamily B member 1, leukocyte immunoglobulin-like receptor subfamily B member 1 soluble isoform, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), LIR1, LIR1LIR-1MIR-7CD85MIR7CD85 antigen, member 1, MIR7, Monocyte/macrophage immunoglobulin-like receptor 7
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.